2.87 (-%)
As of Dec 10, 2024
Source:
Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of innovative engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases.
Country | United States |
Headquarters | philadelphia , pennsylvania |
Phone Number | ( 267 ) 759-3100 |
Industry | manufacturing |
CEO | Steven Nichtberger |
Website | www.cabalettabio.com |